| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2557 | 2019 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2275 | 2006 |
| Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial JB Dixon, PE O’Brien, J Playfair, L Chapman, LM Schachter, S Skinner, ... Jama 299 (3), 316-323, 2008 | 1958 | 2008 |
| Long-term persistence of hormonal adaptations to weight loss P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ... New England Journal of Medicine 365 (17), 1597-1604, 2011 | 1792 | 2011 |
| Evaluating the glucose tolerance test in mice S Andrikopoulos, AR Blair, N Deluca, BC Fam, J Proietto American Journal of Physiology-Endocrinology and Metabolism 295 (6), E1323-E1332, 2008 | 912 | 2008 |
| Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity MEE Jones, AW Thorburn, KL Britt, KN Hewitt, NG Wreford, J Proietto, ... Proceedings of the National Academy of Sciences 97 (23), 12735-12740, 2000 | 880 | 2000 |
| 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 797 | 2017 |
| Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial PE O'Brien, JB Dixon, C Laurie, S Skinner, J Proietto, J McNeil, B Strauss, ... Annals of internal medicine 144 (9), 625-633, 2006 | 683 | 2006 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 593 | 2019 |
| Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling GR Steinberg, BJ Michell, BJW van Denderen, MJ Watt, AL Carey, ... Cell metabolism 4 (6), 465-474, 2006 | 526 | 2006 |
| Ketosis and appetite-mediating nutrients and hormones after weight loss P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ... European journal of clinical nutrition 67 (7), 759-764, 2013 | 419 | 2013 |
| The defence of body weight: a physiological basis for weight regain after weight loss P Sumithran, J Proietto Clinical Science 124 (4), 231-241, 2013 | 381 | 2013 |
| Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes CE Hagberg, A Mehlem, A Falkevall, L Muhl, BC Fam, H Ortsäter, ... Nature 490 (7420), 426-430, 2012 | 320 | 2012 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised … P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ... The lancet Diabetes & endocrinology 5 (11), 864-876, 2017 | 315 | 2017 |
| Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y DA Ainslie, MJ Morris, G Wittert, H Turnbull, J Proietto, AW Thorburn International journal of obesity 25 (11), 1680-1688, 2001 | 301 | 2001 |
| The effect of rate of weight loss on long-term weight management: a randomised controlled trial K Purcell, P Sumithran, LA Prendergast, CJ Bouniu, E Delbridge, ... The Lancet Diabetes & Endocrinology 2 (12), 954-962, 2014 | 273 | 2014 |
| Pharmacotherapy for obesity LL Ioannides-Demos, J Proietto, JJ McNeil Drugs 65, 1391-1418, 2005 | 252 | 2005 |
| Carbohydrate fermentation decreases hepatic glucose output in healthy subjects A Thorburn, J Muir, J Proietto Metabolism 42 (6), 780-785, 1993 | 241 | 1993 |
| Influence of muscle glycogen on glycogenolysis and glucose uptake during exercise in humans M Hargreaves, G McConell, J Proietto Journal of Applied Physiology 78 (1), 288-292, 1995 | 234 | 1995 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ... Diabetes Care 41 (12), 2552-2559, 2018 | 231 | 2018 |
